Trial Profile
A Phase 3, Randomized, Active-Controlled, Double-Blind Trial of the Safety, Tolerability, and Immunologic Non-Inferiority of a 13-Valent Pneumococcal Conjugate Vaccine Compared to a 7-Valent Pneumococcal Conjugate Vaccine in Healthy Infants Given With Routine Pediatric Vaccinations in Germany
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 11 Aug 2012
Price :
$35
*
At a glance
- Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary) ; Hib DTaP hepatitis B poliovirus vaccine (Infanrix hexa); Pneumococcal 7-valent CRM197 vaccine conjugate
- Indications Diphtheria; Haemophilus infections; Hepatitis B; Otitis media; Pertussis; Pneumococcal infections; Pneumonia; Poliomyelitis; Tetanus
- Focus Adverse reactions; Pharmacodynamics; Registrational
- 22 Jun 2011 Results published in Vaccine.
- 29 Oct 2009 Results were presented at IDSA 2009.
- 27 Oct 2008 Study results have been reported at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) and the Infectious Diseases Society of America (IDSA).